Search
for
Sort by
Research 361–390 of 1000+
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Enhanced remyelination during late pregnancy: involvement of the GABAergic system
- Management OF Patients with Polycystic Ovary Syndrom
- Indian Gooseberry (<i>Emblica officinalis</i>Gaertn.)
- Antiandrogen Therapy for Skin and Hair Disease
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Costunolide—A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential
- Alternative Medicine for Hair Loss
- Pilosebaceous Unit (PSU)
- Post-finasteride syndrome – does it really exist?
- Evaluation and treatment of male and female pattern hair loss
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Effect of Pumpkin Seed Oil on Hair Growth in Men with Androgenetic Alopecia: A Randomized, Double-Blind, Placebo-Controlled Trial
- Hormonal manipulation of benign prostatic hyperplasia
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- “Sebocytes’ makeup” - Novel mechanisms and concepts in the physiology of the human sebaceous glands
- Effects of dihydrotestosterone on osteoblast activity in curdlan-administered SKG mice and osteoprogenitor cells in patients with ankylosing spondylitis
- 5α-Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- 5α-reductase Inhibitors: Finasteride and Dutasteride in Feminising Therapy
- Sex-dependent effect of a low neurosteroid environment and intrauterine growth restriction on fetal guinea pig brain development.
- Structure–property relationships of meta-kerateine biomaterials derived from human hair
- Male Pattern Baldness
- Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial
- Congenital adrenal hyperplasia
- Nucleus‐specific modulation of phasic and tonic inhibition by endogenous neurosteroidogenesis in the murine thalamus
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Application of Ostrich Antibodies to the Restoration of Hair Growth, a Preliminary and Case Report
- Metabolic Syndrome in Androgenetic Alopecia in a Tertiary Care Centre in Goa: A Case Control Study During COVID-19 Pandemic
- Pharmacological Options for Treatment of Hyperandrogenic Disorders